A detailed history of Ubs Group Ag transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 71,555 shares of ORIC stock, worth $608,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,555
Previous 80,807 11.45%
Holding current value
$608,217
Previous $571,000 28.37%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $11.9 $69,575 - $110,098
-9,252 Reduced 11.45%
71,555 $733,000
Q2 2024

Aug 13, 2024

SELL
$6.63 - $12.93 $87,874 - $171,374
-13,254 Reduced 14.09%
80,807 $571,000
Q1 2024

May 13, 2024

BUY
$8.04 - $16.03 $426,827 - $851,000
53,088 Added 129.57%
94,061 $1.29 Million
Q4 2023

Feb 09, 2024

BUY
$5.41 - $9.43 $128,222 - $223,500
23,701 Added 137.22%
40,973 $376,000
Q3 2023

Nov 09, 2023

SELL
$6.05 - $9.28 $30,225 - $46,362
-4,996 Reduced 22.44%
17,272 $104,000
Q2 2023

Aug 11, 2023

BUY
$4.95 - $8.4 $110,226 - $187,051
22,268 New
22,268 $172,000
Q4 2022

Feb 08, 2023

BUY
$2.41 - $5.89 $10,363 - $25,327
4,300 Added 3233.08%
4,433 $26,000
Q3 2022

Nov 10, 2022

SELL
$3.15 - $5.24 $6,523 - $10,852
-2,071 Reduced 93.97%
133 $0
Q2 2022

Aug 10, 2022

BUY
$2.7 - $7.07 $5,950 - $15,582
2,204 New
2,204 $10,000
Q1 2022

May 16, 2022

SELL
$4.54 - $16.1 $283,291 - $1 Million
-62,399 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.01 - $20.3 $437,320 - $739,183
36,413 Added 140.13%
62,399 $917,000
Q3 2021

Nov 15, 2021

BUY
$15.9 - $25.22 $298,077 - $472,799
18,747 Added 258.97%
25,986 $544,000
Q2 2021

Aug 13, 2021

SELL
$17.37 - $25.34 $421,483 - $614,875
-24,265 Reduced 77.02%
7,239 $128,000
Q1 2021

May 12, 2021

BUY
$23.67 - $36.85 $709,555 - $1.1 Million
29,977 Added 1963.13%
31,504 $772,000
Q4 2020

Feb 11, 2021

SELL
$20.32 - $39.8 $1,686 - $3,303
-83 Reduced 5.16%
1,527 $52,000
Q3 2020

Nov 12, 2020

SELL
$19.5 - $31.26 $24,063 - $38,574
-1,234 Reduced 43.39%
1,610 $40,000
Q2 2020

Jul 31, 2020

BUY
$25.68 - $38.12 $73,033 - $108,413
2,844 New
2,844 $96,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.